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Inherited erythromelalgia (IEM), characterized by episodic burning pain and
erythema of the extremities, is produced by gain-of-function mutations in so-
dium channel Nav1.7, which is preferentially expressed in nociceptive and sym-
pathetic neurons. Most patients do not respond to pharmacotherapy, although
a few patients have been reported as showing partial relief with lidocaine or
mexiletine. We report here a new IEM Nav1.7 mutation and its favorable re-
sponse to mexiletine. SCN9A exons from the proband were amplified and se-
quenced. Whole-cell patch-clamp analysis was used to characterize wild-type
and mutant Nav1.7 channels in mammalian cells. A 7-year-old girl, with
a two-year history of symmetric burning pain and erythema in her hands and
feet, was diagnosed with erythromelalgia. Treatment with mexiletine reduced
the number and severity of pain episodes. We identified a single nucleotide sub-
stitution (T2616G) in exon 15, not present in 200 ethnically-matched control
alleles, which substitutes valine 872 by glycine (V872G) within DII/S5.
V872G shifts activation by -10 mV, slows deactivation, and generates larger
ramp currents. We observed a stronger use-dependent inhibition by mexiletine
of V872G compared to wild-type channels. The NaV1.7/V872G mutation pro-
vides a molecular basis for DRG hyperexcitability which can produce pain.
While most IEM patients do not respond to pharmacotherapy, this patient
displayed a favorable response to mexiletine, which appears to be due to
use-dependent block of mutant channels. Continued relief from pain, even after
mexiletine was discontinued in this patient, might suggest that early treatment
may slow the progression of the disease.
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Duloxetine, an inhibitor of the serotonin-norepinephrine reuptake system, is
widely used for the treatment of major depression and has also been found to
be effective in reducing neuropathic pain. This latter effect is believed to be re-
lated to the role of the two neurotransmitters in inhibiting pain signals at the
level of spinal and supraspinal neural circuits. However the possibility that du-
loxetine also acts through alternative mechanisms has not yet been investigated.
In this study we focused on the potential effect of duloxetine on neuronal
isoforms of voltage-gated sodium channels (NaV1.3 and NaV1.7) that have
a pivotal role in the generation and propagation of pain signals. Conventional
whole-cell patch-clamp recordings were performed on CHO-cells expressing
hNaV1.3 and hNaV1.7. Duloxetine exerted a concentration-dependent resting
block, measured by the reduction of the sodium current elicited by a single de-
polarizing step from -100mV to 0mV for 10 ms, with IC50 values of 5 and 16
microM for NaV1.3 and NaV1.7, respectively. These values were halved at
holding potentials that reduce channel availability of both channels by 50%, in-
dicating a preference for the inactivated state of sodium channels. Furthermore
we observed that 10 microM duloxetine induced a 10mV negative shift of the
steady state inactivation curves, and preliminary results indicate that this effect
is correlated with stabilization of slow inactivation. Finally, for both sodium
channel isoforms, an additional 20% inhibition over the resting block was ob-
served at concentrations close to the IC50 when the stimulation frequency was
increased up to 10Hz. Thus, the antidepressant duloxetine exhibits most of the
state-dependent mechanisms of a classic sodium channel blocker. These results
may add valuable information about the pharmacological spectrum of duloxe-
tine, an issue of high clinical impact considering its increasingly widespread use.
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It has been recently published that a small molecule, A-803467, selectively in-
hibits hNav1.8 sodium channel subtype and is also efficacious in a variety of
pre-clinical pain models (ref. 1). While A-803467 blocks hNav1.8 with an
IC50 value of 8 nM (at half-maximal inactivation), it also inhibits other sodium
channel subtypes with a selectivity ratio of 30-1000-fold. In particular, it in-
hibits hNav1.3 and hNav1.7 channels, which have connection to pain sensationin animal models (ref. 2), with IC50 values around 1 mM. We suggest that in-
hibition of these channels may also contribute to analgesic efficacy of A-
803467. We therefore were interested in studying biophysical parameters of in-
teraction of A-803467 with hNav1.7 and hNav1.3 channels. We present the data
on the affinity of binding of the drug to the resting and inactivated states of the
channels, as well as the on-rate of binding to inactivated channels, retardation
of repriming and use-dependent block of trains of depolarizing pulses. The bio-
physical profile of A-803467 suggests interaction with a site distinct from the
‘‘classical’’ local anaesthetic receptor site in Nav channels. This profile is com-
pared with the parameters measured for other clinically relevant analgesics.
(1) Jarvis MF, et al. Proc Natl Acad Sci USA 2007; 104:8520-85.
(2) Dib-Hajj SD, et al. Trends in Neurosciences 2007; 30 (11):555-63.
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Recently we indirectly determined the gating charge of single Na-channels
(qNa) to be about 6 e (Gamal El-Din et al., 2008). We compared the ratios
of total fluorescence intensity to total gating charge (Ft/Qt) of EGFP marked
K- and Na-channels expressed in Xenopus laevis oocytes. This allowed to de-
duce qNa from the better known K-channels (qK¼ 13-14 e) without the need to
know the fluorescence intensity of a single EGFP (Fs). Since we used EGFP to
mark and count both channel types, Fs cancelled out in the comparison.
We now attempt to determine and apply Fs to obtain the total number of chan-
nels (Nt ¼ Ft/Fs) and from that q ¼ Qt/Nt directly. As outlined in the above
cited study, Ft was extrapolated to the whole oocyte’s surface from a defined
region along the circumference in order to minimize contributions from sub-
membraneous channels and cytoplasmic autofluorescence. Micrographs of
EGFP solutions of known concentration in a hemocytometer chamber provided
a figure for Fs. However, this figure cannot simply be transferred to the situation
of the oocyte images because it holds true only for EGFP molecules in frontal
areas, accessible for the entire opening of the microscope objective. At lateral
areas of the oocyte the fluorescence intensity is attenuated. The attenuation
was determined by measuring the fluorescence intensity of control oocytes
whose surface was strongly and homogeneously stained with a fluorescent dye
such that autofluorescence from the cytoplasm could be neglected. Comparison
of the extrapolation from either the lateral or the frontal area to the total fluores-
cence of the oocyte (Ft) gave an attenuation factor of 3 to 6 depending on the
optics. This factor was used to obtain the number of EGFP marked channels.
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Upon membrane depolarization, conformational changes in the S4 voltage sen-
sors results in the opening of the voltage-gated sodium channel. The movement
of the positively charged residues on the four distinct voltage-sensors in the
membrane electric field generates a measurable transient current referred to
as the gating current. The ON gating currents of the Naþ channel has two ki-
netic components and the fast component correlates well with the kinetics of
fluorescence changes of probes attached to the voltage sensors of domains I,
II, and III. The slow component of the gating current, however, matches with
the fluorescence kinetics of probes on domain IV voltage-sensor (Chanda
and Bezanilla JGP 2002 120; 629-45). In an attempt to specify the molecular
origin of the slow and fast components of the gating current, we neutralized
the first three charged residues (Q3 mutants) in each of the four voltage-sensing
segments of the sodium channel. Our data supports the hypothesis that the volt-
age-sensor of domain IV primarily contributes to the slow component of the
gating current and provides support to the notion that the movement of this
voltage sensor is slower than the opening of the pore.
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Unlike the gated pore model, which assumes the existence of a movable gate
within the molecule, the gateless gating model (H. R. Leuchtag, Voltage-Sen-
sitive Ion Channels, Springer 2008) (VSIC) explains ion-channel gating as
a phase transition. Under this model, the closed channel conformation imposed
